DALAL KANAAN: Open Payments
NPI 1831872639 · CLEARWATER, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,075 in 50 payments from 17 companies in 2025. Trend: 2023 $108 · 2024 $2,043 · 2025 $2,075
Food & beverage: $1,998Education: $77
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $827 |
| Janssen Biotech, Inc. | 5 | $290 |
| Janssen Scientific Affairs, LLC | 2 | $175 |
| Gilead Sciences, Inc. | 3 | $172 |
| GENZYME CORPORATION | 3 | $95 |
| PFIZER INC. | 1 | $90 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $68 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $68 |
| Madrigal Pharmaceuticals | 2 | $63 |
| SHIELD THERAPEUTICS INC | 2 | $43 |
Products named: TREMFYA, SKYRIZI, RINVOQ, CREON, LINZESS, Livdelzi, VELSIPITY, DUPIXENT.
Industry payments across FL — which companies pay providers there.
